Literature DB >> 24375509

Increased plasma concentration of ribavirin as a result of renal dysfunction in hepatitis C virus patients treated with telaprevir.

Massimo Tempestilli1, Raffaella Lionetti, Gianpiero D'Offizi, Marzia Montalbano, Andrea Giaffreda, Simone Fazio, Leopoldo P Pucillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24375509     DOI： 10.1002/hep.26978

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.

Authors:  Motoyuki Kohjima; Miho Kurokawa; Munechika Enjoji; Tsuyoshi Yoshimoto; Tsukasa Nakamura; Tomoko Ohashi; Kunitaka Fukuizumi; Naohiko Harada; Yusuke Murata; Kazuhisa Matsunaga; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

Review 2.  The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment.

Authors:  Brian P Lam; Thomas Jeffers; Zahra Younoszai; Yousef Fazel; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2015-09       Impact factor: 4.409
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.